Sign In
Buy ZBIO
$17.40
+0.270 (+1.58%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NYSE:ZBIO). Such inv
Levi & Korsinsky Notifies Shareholders of Zenas BioPharma, Inc. (ZBIO) of a Class Action Lawsuit and an Upcoming Deadline
07:30am, Thursday, 24'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zenas BioP
The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ZBIO
05:45am, Thursday, 24'th Apr 2025
NEW YORK , April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO). Shareholders who purchased shares of ZBIO during the
Levi & Korsinsky Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ZBIO
06:30pm, Wednesday, 23'rd Apr 2025
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK CITY, NY / ACCESS Newswire / April 23, 2025 / WHY: New York, N.Y., April 23, 2025.
Investors in Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - ZBIO
04:30pm, Wednesday, 23'rd Apr 2025
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NA
ZBIO LAWSUIT ALERT: The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
01:26pm, Wednesday, 23'rd Apr 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO).
Shareholders that Lost Money on Zenas BioPharma, Inc. (ZBIO) Should Contact Levi & Korsinsky About Pending Class Action - ZBIO
09:45am, Wednesday, 23'rd Apr 2025
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NYSE:ZBIO). Such investor
